Tarsus Pharmaceuticals reported cash from operations of $61.22M and free cash flow of $57.15M for the quarter ended Jun 2026, up 308.3% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -15.36M | -14.49M | -19.84M | -5.47M | -22.47M | -13.63M | -23.34M | -31.41M | -38.95M | -42.46M | -35.55M | -31.28M | -23.49M | -23.09M | -25.04M | -20.20M | -12.68M | -6.24M | -6.93M | -21.08M | ||||||||
| Share-based CompensationStock Comp. | 0.07M | 2.18M | 2.67M | 3.53M | 3.58M | 3.67M | 3.91M | 5.19M | 5.25M | 5.48M | 5.52M | 7.48M | 7.42M | 7.40M | 6.93M | 8.23M | 12.24M | 14.31M | 11.97M | 13.29M | ||||||||
| Cash from OperationsCash from Ops. | 7.11M | -12.12M | -15.29M | -4.26M | -18.61M | -10.87M | -21.97M | -23.83M | -32.36M | -39.34M | -37.79M | -14.40M | -8.65M | -22.18M | -20.65M | -29.39M | 18.26M | 19.33M | -24.65M | 61.22M | ||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | -0.09M | 0.29M | 0.06M | 1.25M | 1.48M | 1.07M | 0.49M | 0.12M | 0.29M | 1.30M | 1.14M | 1.48M | 1.31M | 1.71M | 1.53M | 0.93M | 0.85M | 0.76M | ||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.06M | 0.04M | 0.05M | 0.08M | 0.08M | 0.03M | 0.03M | 0.11M | 0.11M | 0.10M | 0.13M | 0.14M | 0.14M | 0.15M | 0.15M | 0.16M | 0.16M | 0.17M | ||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -20.00M | 0.02M | -0.02M | 2.50M | -2.50M | 5.36M | 11.26M | 13.26M | -0.36M | -0.37M | 17.60M | 15.67M | -4.09M | 14.29M | 12.44M | 30.29M | -19.32M | |||||||||||
| Change in InventoryChange Inventory | 0.01M | 3.09M | 0.93M | 0.69M | 0.65M | -0.23M | 0.08M | 1.17M | -0.04M | 0.54M | 0.20M | -0.20M | ||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | -1.10M | 0.36M | 1.97M | -2.10M | 1.43M | 1.43M | -1.31M | 0.68M | 5.81M | 3.53M | 12.34M | 7.09M | 5.87M | 12.50M | 10.16M | 3.17M | 24.11M | 7.94M | 15.46M | 13.30M | ||||||||
| Investing Activities | ||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.44M | -0.50M | 0.16M | 0.12M | 0.10M | 0.13M | 0.34M | 0.79M | 0.38M | 0.17M | 1.04M | 0.28M | 0.07M | 0.59M | 1.00M | 1.91M | 6.36M | 5.82M | 4.07M | |||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 5.32M | 40.30M | 64.88M | 51.74M | 17.85M | 2.50M | 10.54M | 24.50M | 35.47M | 91.22M | 79.00M | 99.50M | 92.08M | 74.06M | 44.35M | |||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.12M | -0.27M | -0.16M | -0.12M | -57.13M | -87.22M | 11.29M | 64.09M | 47.37M | 17.85M | -102.22M | -40.52M | 3.13M | -59.57M | -34.94M | -51.70M | -4.74M | 49.27M | -58.56M | 37.88M | ||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.22M | 0.22M | 0.24M | 0.01M | 0.45M | 0.11M | 0.41M | 9.37M | 1.44M | 1.21M | 2.56M | 1.08M | 1.20M | 1.86M | ||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.07M | -0.07M | 19.12M | 74.73M | -0.14M | 0.26M | 5.01M | 0.51M | 104.89M | 19.76M | 108.77M | 42.32M | 0.64M | 2.93M | 136.56M | 1.95M | 2.56M | 2.31M | 1.20M | 3.30M | ||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | -0.22M | 99.38M | -0.02M | 98.60M | -0.27M | -0.04M | 135.12M | -0.35M | ||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||
| Change in Cash | 7.07M | -12.47M | 3.68M | 70.35M | -75.87M | -97.83M | -5.66M | 40.78M | 119.90M | -1.73M | -31.24M | -12.61M | -4.88M | -78.83M | 80.97M | -79.14M | 16.08M | 70.92M | -82.01M | 102.40M | ||||||||
| Free Cash FlowFCF | 6.68M | -11.62M | -15.45M | -4.38M | -18.71M | -11.00M | -22.31M | -24.61M | -32.74M | -39.34M | -37.96M | -15.44M | -8.93M | -22.25M | -21.24M | -30.39M | 16.35M | 12.97M | -30.47M | 57.15M | ||||||||
| Net Cash FlowNCF | 7.07M | -12.47M | 3.68M | 70.35M | -75.87M | -97.83M | -5.66M | 40.78M | 119.90M | -1.73M | -31.24M | -12.61M | -4.88M | -78.83M | 80.97M | -79.14M | 16.08M | 70.92M | -82.01M | 102.40M |